
    
      At least 150 subjects with osteoarthritic knee will be recruited and computer randomized
      1:1:1:1 to single injection of ASA (40mg), ASA (20mg), PRP + HA, and NS groups. Both subjects
      and evaluaters were blinded to allocations. Functional and radiologic outcomes were measured
      at baseline, and 1 week, 1, 3, 6, 12 months postinjection.
    
  